logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shuji Murakami

kanagawa prefectural cancer center
H指数:36
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning–based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors

基于机器学习的循环自身抗体动力学和治疗结局在NSCLC接受免疫检查点抑制剂治疗患者中的洞察

Frontiers in Immunology
IF5.9
2025-10-030
OAAI
Feifei Wei‡; Hiroyuki Takeda‡; Koichi Azuma‡; Yoshiro Nakahara; Yuka Igarashi; Kenta Murotani; Haruhiro Saito; Shuji Murakami; Tetsuro Kondo; Taku Kouro; Hidetomo Himuro; Kayoko Tsuji; Mitsuru Komahashi; Tatsuya Sawasaki†; Tetsuro Sasada†
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors

LP-300联合卡铂和培美曲塞治疗既往接受过酪氨酸激酶抑制剂治疗的从不吸烟的复发进展期原发性肺腺癌患者的II期临床试验

Clinical Lung Cancer
IF3.3
2025-05-280
PRE
J. Nicholas Bodor; Jonathan Dowell; Joseph Treat; Janakiraman Subramanian; Nihal Abdulla; Eric Lee; Kamlesh Sankhala; Chun-Hui Lee; Go Makimoto; Eisaku Miyauchi; Kartik Konduri; Hajime Asahina; Shuji Murakami; Yueh-Feng Wen; Yung-Hung Luo; Shan Yueh Chang; Reginald Ewesuedo; Jianli Zhou; Yasushi Goto
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-11-011
PRE
Shiraishi, Yoshimasa; Nomura, Shogo; Sugawara, Shunichi; Horinouchi, Hidehito; Yoneshima, Yasuto; Hayashi, Hidetoshi; Azuma, Koichi; Hara, Satoshi; Niho, Seiji; Morita, Ryo; Yamaguchi, Masafumi; Yokoyama, Toshihide; Yoh, Kiyotaka; Kurata, Takayasu; Okamoto, Hiroaki; Okamoto, Masaki; Kijima, Takashi; Kasahara, Kazuo; Fujiwara, Yutaka; Murakami, Shuji; Kanda, Shintaro; Akamatsu, Hiroaki; Takemoto, Shinnosuke; Kaneda, Hiroyasu; Kozuki, Toshiyuki; Ando, Masahiko; Sekino, Yuta; Fukuda, Haruhiko; Ohe, Yuichiro; Okamoto, Isamu
A phase 3 multicenter study to evaluate the accuracy and clinical usefulness of the high- sensitivity next-generation sequencing panel using cytological specimens for lung cancer (cPANEL)
EUROPEAN RESPIRATORY JOURNAL
IF21
2024-10-300
PRE
Morikawa, Kei; Takashima, Yuta; Oki, Masahide; Tsuzuku, Akifumi; Murakami, Shuji; Minami, Daisuke; Fujii, Shinji; Shinagawa, Naofumi; Asano, Fumihiro; Nakamura, Seiji; Sato, Yoshiharu; Ueda, Yumi; Suzuki, Fumihiko; Yokose, Tomoyuki; Tanabe, Kenichiro; Mineshita, Masamichi
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

血浆中性粒细胞胞外诱捕网水平对接受免疫检查点抑制剂治疗的非小细胞肺癌患者的预后意义

BIOMEDICINES
IF3.9
2024-08-120
OAAI
Horaguchi, Shun; Nakahara, Yoshiro; Igarashi, Yuka; Kouro, Taku; Wei, Feifei; Murotani, Kenta; Udagawa, Seiichi; Higashijima, Naoko; Matsuo, Norikazu; Murakami, Shuji; Kato, Terufumi; Kondo, Tetsuro; Xiang, Huihui; Kasajima, Rika; Himuro, Hidetomo; Tsuji, Kayoko; Mano, Yasunobu; Komahashi, Mitsuru; Miyagi, Yohei; Saito, Haruhiro; Azuma, Koichi; Uehara, Shuichiro; Sasada, Tetsuro
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

不可切除的III期NSCLC同步放化疗后Durvalumab的症状性肺炎

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-03-013
OA
Vansteenkiste, Johan F.; Naidoo, Jarushka; Faivre-Finn, Corinne; Ozguroglu, Mustafa; Villegas, Augusto; Daniel, Davey; Murakami, Shuji; Hui, Rina; Lee, Ki Hyeong; Cho, Byoung Chul; Kubota, Kaoru; Broadhurst, Helen; Wadsworth, Catherine; Newton, Michael; Thiyagarajah, Piruntha; Antonia, Scott J.
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

前瞻性观察研究，以探索预测布格替尼对ALK基因重排非小细胞肺癌的疗效和安全性的基因和蛋白质: ABRAID研究的研究方案 (WJOG11919L)

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-01-270
OAAI
Ozawa, Yuichi; Koh, Yasuhiro; Hase, Tetsunari; Chibana, Kenji; Kaira, Kyoichi; Okishio, Kyoichi; Ichihara, Eiki; Murakami, Shuji; Shimokawa, Mototsugu; Yamamoto, Nobuyuki
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study)
CLINICAL CANCER RESEARCH
IF10.2
2024-01-021
OAAI
Nakamichi, Shinji; Kubota, Kaoru; Misumi, Toshihiro; Kondo, Tetsuro; Murakami, Shuji; Shiraishi, Yoshimasa; Imai, Hisao; Harada, Daijiro; Isobe, Kazutoshi; Itani, Hidetoshi; Takata, Saori; Wakui, Hiroshi; Misumi, Yuki; Ikeda, Satoshi; Asao, Tetsuhiko; Furuya, Naoki; Hosokawa, Shinobu; Kobayashi, Yumiko; Takiguchi, Yuichi; Okamoto, Hiroaki
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures

基于循环细胞因子特征的机器学习预测非小细胞肺癌免疫治疗结果

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2023-07-1117
OAAI
Wei, Feifei; Azuma, Koichi; Nakahara, Yoshiro; Saito, Haruhiro; Matsuo, Norikazu; Tagami, Tomoyuki; Kouro, Taku; Igarashi, Yuka; Tokito, Takaaki; Kato, Terufumi; Kondo, Tetsuro; Murakami, Shuji; Usui, Ryo; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Murotani, Kenta; Ban, Tatsuma; Tamura, Tomohiko; Miyagi, Yohei; Sasada, Tetsuro
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-05-012
OA
Goto, Yasushi; Kenmotsu, Hirotsugu; Tamiya, Motohiro; Murakami, Shuji; Kurata, Takayasu; Yanagitani, Noriko; Taniguchi, Hirokazu; Kuyama, Shoichi; Shimizu, Junichi; Yokoyama, Toshihide; Shimada, Naoko; Maeda, Tadashi; Tamiya, Akihiro; Uchiyama, Ayumi; Imaizumi, Kazuyoshi; Takahama, Takayuki; Kato, Terufumi; Hayashi, Hidetoshi; Shiraiwa, Naoko; Toyoizumi, Shigeyuki; Kikkawa, Hironori; Thomaidou, Despina; Nishio, Makoto
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
SCIENTIFIC REPORTS
IF3.9
2023-03-063
OAAI
Fujimoto, Daichi; Miura, Satoru; Tomii, Keisuke; Sumikawa, Hiromitsu; Yoshimura, Kenichi; Wakuda, Kazushige; Oya, Yuko; Yokoyama, Toshihide; Kijima, Takashi; Asao, Tetsuhiko; Tamiya, Motohiro; Nakamura, Atsushi; Yoshioka, Hiroshige; Tokito, Takaaki; Murakami, Shuji; Tamiya, Akihiro; Yokouchi, Hiroshi; Watanabe, Satoshi; Yamaguchi, Ou; Morinaga, Ryotaro; Jodai, Takayuki; Ito, Kentaro; Shiraishi, Yoshimasa; Kogure, Yoshihito; Shibaki, Ryota; Yamamoto, Nobuyuki

研究方向

暂未获取到该数据
H
Haruhiro Saito
H 指数:31论文数:247被引数:6,703
T
Tetsuro Kondo
H 指数:23论文数:209被引数:2,628
H
Hiroyuki Ito
H 指数:42论文数:383被引数:8,320
H
Haruhiko Nakayama
H 指数:45论文数:376被引数:7,145
T
Tomoyuki Yokose
H 指数:0论文数:0被引数:6
M
Mustafa Özgüroğlu
H 指数:61论文数:549被引数:4.2万
R
Rina Hui
H 指数:63论文数:252被引数:4.7万
D
Davey B. Daniel
H 指数:28论文数:134被引数:1.3万
T
Terufumi Kato
H 指数:58论文数:521被引数:2.9万
A
Augusto Villegas
H 指数:15论文数:60被引数:8,745